Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CVIA 106 pentavalent meningococcal ACWYX conjugate vaccine study
PACTR202407771418605Phase 2Recruiting
- Sponsor
- EuBiologics
- Start
- Aug 2024
- Countries
- 2
01
Overview
Phase 2 trial in meningococcal disease (3 arms), sponsored by EuBiologics. Started Aug 2024; status: recruiting.
02
Conditions
meningococcal disease
Beyond the preview
Go deeper on PACTR202407771418605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202407771418605.